ACB

Conviction 63HealthcareScan · Fri, Oct 16, 2026

Aurora Cannabis Inc (ACB) closed at $4.00 (-2.56%) on Oct 16, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 46, RS Rating 87, -28.3% from its 52-week high, -8.0% year to date. Sector: Healthcare · Drug Manufacturers - Specialty & Generic.

ACB$4.00-2.56%

ResistanceSupportVol 14

Vol MA14 1.29M

Jul 21Aug 6Aug 25Sep 11Sep 30Oct 16

Aurora Cannabis IncDrug Manufacturers - Specialty & Genericwww.auroramj.com ↗

Price4.00

Change-2.56%

Gap-0.12%

Rel volume0.66×

Avg volume1.17M

Avg $ vol5.02M

SMA 204.20

SMA 503.96

SMA 2003.55

Price vs 50+0.95%

Price vs 200+12.41%

MA stackbullish

50/200 cross—

Supertrendup · 3.95

RSI (14)46

MACD hist-0.04

MACD crossbear · 2d

Stoch %K / %D21 / 32

ADX (14)25

+DI / −DI25 / 25

RSI divergenceBearish

MACD divergence—

ATR %4.37%

ADR %3.89%

52w high5.57

52w low2.58

From 52w high-28.28%

Above 52w low+54.84%

New 52w highNo

SqueezeOff

Bollinger width19.68%

%B0.25

Donchian pos21.05%

Donchian high4.67

Donchian low3.82

AVWAP (52w high)3.73

vs AVWAP high+7.08%

AVWAP (52w low)3.65

vs AVWAP low+9.40%

OBV trendFlat

Chaikin MF (20)-0.07

Today vs 20d0.66×

Avg vol (14d)1.29M

Avg vol (20d)1.17M

Avg $ vol (20d)5.02M

Market cap224.66M

RS Rating87 / 99

RS 3m (vs SPY)+51.38%

RS 6m (vs SPY)+1.66%

RS line new highNo

Trend template4/8

Technical rank80.1

1 week-11.02%

1 month+3.77%

3 months+54.25%

6 months+9.15%

1 year-29.04%

YTD-7.95%

P/E—

P/B—

P/S—

P/FCF—

EPS—

Div yield—

ROE—

ROA—

Debt/Eq—

Current—

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target4.23

Target upside5.88%

Analyst ratingHold

Institutional8.42%

Ent. value224.66M

Revenue—

Net income—

Gross profit—

Free cash flow—

IndustryDrug Manufacturers - Specialty & Generic

ExchangeNasdaq

Shares out61.34M

Employees1.1K

ListedThu, Jul 10, 2014

Free float56.43M

Float %99.5%

Short interest7.31M

Days to cover5.5d

Short volume65.9%

Squeeze score68 / 100

Next earnings—

EPS forecast—

Last EPS vs est$0.04 vs −$0.13

Last surprise+130.8% beat

Setup gradeB

Conviction63 / 100

Pattern quality—

Tech rank80.1 / 100

Group rank5 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance4.49

Support3.75

Days since event—

Candle confirm—

Congress activity

Disclosed STOCK Act trades in ACB

All disclosures →

No recent disclosed trades by Congress in ACB. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ACB

No recent insider (Form 4) filings in ACB. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in ACB · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.

ACB

Recent news

Get daily signals & real-time alerts.